Equity Capital Markets
Taysha Gene Therapies
05/25
|
$200.0 Million
Âé¶¹´«Ã½ served as bookrunner for Taysha Gene Therapies on its CMFO
Sub-Type
Confidentially Marketed Follow-On Offering
Sector
Sub-Sector
Biopharma